Meeting Banner
Abstract #3586

Labelling of collagen type I templates with a novel naturally derived contrast agent for magnetic resonance imaging in soft tissue engineering

Heinz Peter Janke1, Nihan G├╝vener2, Weiqiang Dou3, Jozef Cremers4, Paul Borm4, Wout Feitz5, Arend Heerschap3, Fabian Kiessling2, and Egbert Oosterwijk1

1Urology, Radboud University Medical Center; Radboud Institute for Molecular Life Sciences, Nijmegen, Netherlands, 2Experimental Molecular Imaging, Uniklinik RWTH and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany, 3Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, Netherlands, 4Nano4Imaging, Aachen, Germany, 5Urology, Radboud University Medical Center; Radboud Institute for Molecular Life Sciences; Radboudumc Amalia Children's Hospital, Nijmegen, Netherlands

Contrast agents (CA) need to be applied for monitoring tissue-engineered implants by MR imaging. However, currently used CAs have limitations (i.e. negative contrast, label instability). In this study, Hemin-Lysine complex (HL) -as a naturally derived alternative CA- is used for active labeling of hybrid collagen-based templates. HL-labeled templates are clearly identified because of their bright signal in T1-weighted MR images. The signal of labeled templates and thus their integrity could be followed over time when subcutaneously implanted in a mouse model. Thus, loading collagen-based templates with HL appears to be a promising strategy to localize and monitor its fate upon implantation.

This abstract and the presentation materials are available to members only; a login is required.

Join Here